Skip to content
PatentBrief

Company Portfolio

Curevac SE

Patents indexed

2

Year range

2024

biotechpharmaceuticaloncologygene_editingimmunotherapy

Key Inventors

Thomas Lander1Ingmar Hoerr1Jochen Probst1Margit Schnee1Thomas Kramps1Benjamin Petsch1Lothar Stitz1

All Patents

2

Career timeline

2 patents, in 2024

Dot size = forward citations

20242025

Hover or tap any dot to see the patent. Larger dots indicate more forward citations — a proxy for downstream influence.

US 12048738·2024

Using mRNA to Teach the Body to Fight Prostate Cancer

This patent describes an active composition, often a vaccine, that uses messenger RNA (mRNA) to instruct a mammal's cells to produce specific prostate cancer proteins, thereby training the immune system to attack prostate cancer cells.

US 12083190·2024

How an mRNA Vaccine Teaches Your Body to Fight Rabies

This patent describes a method for creating an immune response against the rabies virus by injecting a specific messenger RNA molecule that instructs cells to produce a key rabies protein.

Patent monitoring

Get notified when Curevac SE files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.